Chemed Corporation (NYSE:CHE) Q3 2025 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to the Chemed Corporation Third Quarter 2025 Earnings Conference Call.
Chemed Corp (CHE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 2,300 | $1,029,802 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $417.10 | 200 | $83,420.00 | 3,523 | 2025-08-04 | Filing | |
| $519.50 | 145 | $75,327.50 | 1,678 | 2024-12-30 | Filing | |
| $509.34 | 4 | $2,037.36 | 3,068 | 2022-12-30 | Filing | |
| $531.29 | 1 | $531.29 | 63 | 2021-12-31 | Filing | |
| $531.29 | 40 | $21,251.60 | 5,736 | 2021-12-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $461.28 | 3,000 | $1,383,840.00 | 96,197 | 2025-09-26 | Filing | |
| $463.39 | 150 | $69,508.50 | 3,397 | 2025-09-09 | Filing | |
| $428.55 | 2,000 | $857,100.00 | 99,197 | 2025-08-05 | Filing | |
| $421.91 | 10,012 | $4,224,162.92 | 0 | 2025-08-04 | Filing | |
| $577.99 | 1,500 | $866,985.00 | 14,627 | 2025-05-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 234,466 | $104,979,937 | 0.77% | |
| 2. | 146,366 | $65,534,365 | 1.37% | |
| 3. | 111,033 | $49,713,915 | 1.67% | |
| 4. | 95,205 | $42,627,093 | 0.99% | |
| 5. | 83,704 | $36,883,330 | 0.06% |
News See All
Here’s How Chemed Corp. (CHE) Building Long-Term Shareholder Value
LRT Capital Management, an investment management company, released its “LRT Global Opportunities Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Chemed Corporation (CHE): A Bull Case Theory
We came across a bullish thesis on Chemed Corporation on The Buyside Guy’s Substack by The Buyside Guy. In this article, we will summarize the bulls’ thesis on CHE.
Chemed Corporation (NYSE:CHE) Q2 2025 Earnings Call Transcript
Operator: Hello, and welcome to Chemed Corporation's Second Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to Holley Schmidt.
Chemed updates 2025 forecast as Q1 revenue shows continued growth
Ohio-based company, Chemed Corporation (NYSE:CHE) operates two main subsidiaries, VITAS Healthcare and Roto-Rooter.
11 Best Long Term Low Risk Stocks to Invest in
The uncertainty prevailing in the current market environment demands a closer examination beyond just earnings reports and share price trends when seeking a worthy investment.
Chemed Corporation (CHE): A Bull Case Theory
We came across a bullish thesis on Chemed Corporation on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on CHE.
Chemed (CHE) Fell due to Concerns Over Potential Medicare Cap Limits
Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here.
RBC Capital Lowered Firm's PT on Chemed Corporation (CHE), Kept a Buy Rating
Chemed Corporation (NYSE:CHE) is one of the Best 52-Week Low Stocks to Buy According to Analysts.
12 Best 52-Week Low Stocks to Buy According to Analysts
On July 15, the Consumer Price Index data revealed that core inflation increased by 0.2% on the month; however, the annual rate of 2.9% remains within the estimated range.